Oblique Therapeutics and Eli Lilly to apply the AbiProt technology to generate antibodies to a high-value target

This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties

Novartis and Versant to form biotech venture Borealis Biosciences

Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company

Aayush Wellness enters nutraceutical market with Dreamy Sleep Gummies

UK Relonchem receives marketing authorization for Levonorgestrel 1.5 mg Tablets

Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA

Emmes partners with Miimansa AI to accelerate adoption of Generative AI in clinical research

The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data

Zydus and Dr. Reddy's announce licensing agreement for co?marketing of Pertuzumab biosimilar

Gavi outlines plans to support access to new vaccines

The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030

Bayer starts Phase I study with novel targeted radionuclide therapy in advanced metastatic prostate cancer

225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer

Novartis to acquire Mariana Oncology for upfront US$ 1 billion

Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications

Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome

Around 7% of the Indian population suffers from IBS